Abstract Background and aims CADASIL is the most common monogenic cerebral small vessel disease and an important cause of ischemic stroke and vascular cognitive impairment in young and middle-aged adults. We aimed to characeterize and evaluate clinical severity of CADASIL in Portugal. Methods We conducted a cross-sectional, multicenter, study including patients with CADASIL and asymptomatic carriers of a NOTCH3 mutation. Demographic, genetic, and clinical data were obtained and brain MRIs were reviewed. Condition severity was assessed by CADASIL Clinical Severity Grading Scale and NOTCH3-SVD Staging System. Statistical analysis was performed using SPSS®. Results We included 138 individuals, 16% asymptomatic carriers of NOTCH3 mutation, 62.3% females, median age of 62 years (IQR 15). Family history of CADASIL was present in 58% of cases. Pathogenic variants c.1672CT p.(Arg558Cys) and c.1258GT p.(Gly420Cys) were the most frequently identified. Ischemic stroke and transient ischemic attacks were the predominant clinical presentations. Cognitive impairment and migraine-like headache was observed in 42% and 30% of cases, respectively. Two or more additional cerebrovascular risk factors were present in 60% of cases. Antiplatelet agents, statins and antidementia medication were taken by 66%, 57% and 20%, respectively. High disease severity (stage ≥3) was identified in 20% of cases. Stages 1 and 2 were obtained with the NOTCH3-SVD Staging System in 40% and 30% of cases of asymptomatic carriers, respectively. Conclusions This cohort highlights the high burden of CADASIL in Portugal and suggests a clinico-radiological mismatch in early stages. Early diagnosis may facilitate timely vascular risk factor management and improve neurological outcomes. Conflict of interest Carla Morgado: nothing to disclose, Aurora Costa: nothing to disclose, Daniela Ferro: nothing to disclose, Jorge Machado: nothing to disclose, Mariana Henriques: nothing to disclose, Mariana Perdicoulis: nothing to disclose, Sofia Pinto: nothing to disclose, Bárbara Rodrigues: nothing to disclose , Inês Carvalho: nothing to disclose , José Fins: nothing to disclose , Luís Costa: nothing to disclose , Beatriz Marques: nothing to disclose, Mariana Gomes: nothing to disclose, Miguel Peliteiro: nothing to disclose, André Rego: nothing to disclose, Maria João Lima: nothing to disclose, Luís Maia: nothing to disclose, Elsa Azevedo: nothing to disclose, Miguel Viana-Baptista: nothing to disclose, Ana Rita Silva: nothing to disclose
Building similarity graph...
Analyzing shared references across papers
Loading...
Morgado et al. (Fri,) studied this question.
synapsesocial.com/papers/69fd7fb8bfa21ec5bbf08501 — DOI: https://doi.org/10.1093/esj/aakag023.1684
Carla Morgado
Hospital Braga
Aurora Costa
Hospital Braga
Miguel Peliteiro
Hospital de São João
European Stroke Journal
Universidade do Porto
Universidade Nova de Lisboa
University of Trás-os-Montes and Alto Douro
Building similarity graph...
Analyzing shared references across papers
Loading...
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: